nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—DDC—blood plasma—systemic lupus erythematosus	0.0104	0.0485	CbGeAlD
L-DOPA—Mimosine—CCL2—systemic lupus erythematosus	0.0101	0.686	CrCbGaD
L-DOPA—PSIP1—nephron tubule—systemic lupus erythematosus	0.00937	0.0439	CbGeAlD
L-DOPA—SLC7A5—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00903	0.609	CbGdCrCtD
L-DOPA—PSIP1—cortex of kidney—systemic lupus erythematosus	0.00802	0.0376	CbGeAlD
L-DOPA—PSIP1—lymphoid tissue—systemic lupus erythematosus	0.00708	0.0331	CbGeAlD
L-DOPA—PSIP1—bone marrow—systemic lupus erythematosus	0.00644	0.0302	CbGeAlD
L-DOPA—SLC7A8—nephron tubule—systemic lupus erythematosus	0.00618	0.0289	CbGeAlD
L-DOPA—PSIP1—lung—systemic lupus erythematosus	0.00584	0.0273	CbGeAlD
L-DOPA—SLC7A8—skin of body—systemic lupus erythematosus	0.00576	0.027	CbGeAlD
L-DOPA—SLC7A8—kidney—systemic lupus erythematosus	0.00543	0.0254	CbGeAlD
L-DOPA—PSIP1—nervous system—systemic lupus erythematosus	0.00541	0.0253	CbGeAlD
L-DOPA—DDC—nephron tubule—systemic lupus erythematosus	0.00535	0.025	CbGeAlD
L-DOPA—SLC7A8—cortex of kidney—systemic lupus erythematosus	0.00529	0.0248	CbGeAlD
L-DOPA—PSIP1—central nervous system—systemic lupus erythematosus	0.0052	0.0244	CbGeAlD
L-DOPA—CYP2D6—urine—systemic lupus erythematosus	0.00518	0.0243	CbGeAlD
L-DOPA—SLC7A5—connective tissue—systemic lupus erythematosus	0.00494	0.0231	CbGeAlD
L-DOPA—SLC7A5—nephron tubule—systemic lupus erythematosus	0.00479	0.0224	CbGeAlD
L-DOPA—DDC—kidney—systemic lupus erythematosus	0.0047	0.022	CbGeAlD
L-DOPA—DDC—cortex of kidney—systemic lupus erythematosus	0.00458	0.0214	CbGeAlD
L-DOPA—SLC7A5—skin of body—systemic lupus erythematosus	0.00446	0.0209	CbGeAlD
L-DOPA—SLC7A8—tendon—systemic lupus erythematosus	0.00438	0.0205	CbGeAlD
L-DOPA—SLC7A5—cortex of kidney—systemic lupus erythematosus	0.0041	0.0192	CbGeAlD
L-DOPA—SLC15A1—nephron tubule—systemic lupus erythematosus	0.00397	0.0186	CbGeAlD
L-DOPA—DRD5—lymphoid tissue—systemic lupus erythematosus	0.00388	0.0182	CbGeAlD
L-DOPA—SLC7A8—lung—systemic lupus erythematosus	0.00385	0.018	CbGeAlD
L-DOPA—SLC16A10—nephron tubule—systemic lupus erythematosus	0.00367	0.0172	CbGeAlD
L-DOPA—SLC7A5—lymphoid tissue—systemic lupus erythematosus	0.00361	0.0169	CbGeAlD
L-DOPA—SLC7A8—nervous system—systemic lupus erythematosus	0.00356	0.0167	CbGeAlD
L-DOPA—SLC15A1—kidney—systemic lupus erythematosus	0.00349	0.0163	CbGeAlD
L-DOPA—SLC7A8—central nervous system—systemic lupus erythematosus	0.00343	0.0161	CbGeAlD
L-DOPA—SLC7A5—tendon—systemic lupus erythematosus	0.0034	0.0159	CbGeAlD
L-DOPA—DDC—lung—systemic lupus erythematosus	0.00333	0.0156	CbGeAlD
L-DOPA—SLC7A5—bone marrow—systemic lupus erythematosus	0.00329	0.0154	CbGeAlD
L-DOPA—DRD3—nervous system—systemic lupus erythematosus	0.00316	0.0148	CbGeAlD
L-DOPA—SLC16A10—cortex of kidney—systemic lupus erythematosus	0.00314	0.0147	CbGeAlD
L-DOPA—DDC—nervous system—systemic lupus erythematosus	0.00308	0.0144	CbGeAlD
L-DOPA—DRD3—central nervous system—systemic lupus erythematosus	0.00305	0.0143	CbGeAlD
L-DOPA—SLC7A5—lung—systemic lupus erythematosus	0.00298	0.014	CbGeAlD
L-DOPA—DDC—central nervous system—systemic lupus erythematosus	0.00297	0.0139	CbGeAlD
L-DOPA—DRD5—nervous system—systemic lupus erythematosus	0.00296	0.0139	CbGeAlD
L-DOPA—DRD5—central nervous system—systemic lupus erythematosus	0.00285	0.0134	CbGeAlD
L-DOPA—SLC16A10—lymphoid tissue—systemic lupus erythematosus	0.00277	0.013	CbGeAlD
L-DOPA—SLC7A5—nervous system—systemic lupus erythematosus	0.00276	0.0129	CbGeAlD
L-DOPA—CYP2D6—blood plasma—systemic lupus erythematosus	0.0027	0.0127	CbGeAlD
L-DOPA—SLC7A5—central nervous system—systemic lupus erythematosus	0.00266	0.0124	CbGeAlD
L-DOPA—SLC16A10—tendon—systemic lupus erythematosus	0.0026	0.0122	CbGeAlD
L-DOPA—SLC16A10—lung—systemic lupus erythematosus	0.00228	0.0107	CbGeAlD
L-DOPA—DRD1—nervous system—systemic lupus erythematosus	0.00226	0.0106	CbGeAlD
L-DOPA—DRD1—central nervous system—systemic lupus erythematosus	0.00218	0.0102	CbGeAlD
L-DOPA—Mesalazine—PPARG—systemic lupus erythematosus	0.00166	0.112	CrCbGaD
L-DOPA—DRD2—lung—systemic lupus erythematosus	0.00144	0.00676	CbGeAlD
L-DOPA—DRD2—nervous system—systemic lupus erythematosus	0.00134	0.00626	CbGeAlD
L-DOPA—DRD2—central nervous system—systemic lupus erythematosus	0.00129	0.00603	CbGeAlD
L-DOPA—CYP2D6—kidney—systemic lupus erythematosus	0.00123	0.00574	CbGeAlD
L-DOPA—Aminosalicylic Acid—PTGS2—systemic lupus erythematosus	0.000894	0.0605	CrCbGaD
L-DOPA—PSIP1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000885	0.0597	CbGdCrCtD
L-DOPA—Epinephrine—TNF—systemic lupus erythematosus	0.000851	0.0575	CrCbGaD
L-DOPA—CYP2D6—nervous system—systemic lupus erythematosus	0.000804	0.00376	CbGeAlD
L-DOPA—CYP2D6—central nervous system—systemic lupus erythematosus	0.000774	0.00362	CbGeAlD
L-DOPA—SLC7A5—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	0.000765	0.0516	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	0.000722	0.0487	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Betamethasone—systemic lupus erythematosus	0.000711	0.0479	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Dexamethasone—systemic lupus erythematosus	0.000711	0.0479	CbGdCrCtD
L-DOPA—Mesalazine—PTGS2—systemic lupus erythematosus	0.000702	0.0475	CrCbGaD
L-DOPA—SLC7A5—Desoximetasone—Triamcinolone—systemic lupus erythematosus	0.000694	0.0468	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisone—systemic lupus erythematosus	0.000659	0.0445	CbGdCrCtD
L-DOPA—SLC7A5—Desoximetasone—Prednisolone—systemic lupus erythematosus	0.000643	0.0434	CbGdCrCtD
L-DOPA—Liothyronine—ALB—systemic lupus erythematosus	0.000538	0.0364	CrCbGaD
L-DOPA—Shock—Triamcinolone—systemic lupus erythematosus	0.000418	0.000965	CcSEcCtD
L-DOPA—Insomnia—Prednisolone—systemic lupus erythematosus	0.000418	0.000965	CcSEcCtD
L-DOPA—Alopecia—Prednisone—systemic lupus erythematosus	0.000417	0.000964	CcSEcCtD
L-DOPA—Shock—Methylprednisolone—systemic lupus erythematosus	0.000417	0.000963	CcSEcCtD
L-DOPA—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000415	0.000959	CcSEcCtD
L-DOPA—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000415	0.000959	CcSEcCtD
L-DOPA—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000415	0.000959	CcSEcCtD
L-DOPA—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000415	0.000958	CcSEcCtD
L-DOPA—Rash—Leflunomide—systemic lupus erythematosus	0.000415	0.000958	CcSEcCtD
L-DOPA—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000414	0.000957	CcSEcCtD
L-DOPA—Mental disorder—Prednisone—systemic lupus erythematosus	0.000414	0.000956	CcSEcCtD
L-DOPA—Nausea—Azathioprine—systemic lupus erythematosus	0.000414	0.000955	CcSEcCtD
L-DOPA—Headache—Leflunomide—systemic lupus erythematosus	0.000412	0.000952	CcSEcCtD
L-DOPA—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000411	0.000948	CcSEcCtD
L-DOPA—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.00041	0.000948	CcSEcCtD
L-DOPA—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.00041	0.000946	CcSEcCtD
L-DOPA—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000409	0.000945	CcSEcCtD
L-DOPA—Convulsion—Betamethasone—systemic lupus erythematosus	0.000409	0.000945	CcSEcCtD
L-DOPA—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000408	0.000942	CcSEcCtD
L-DOPA—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000408	0.000942	CcSEcCtD
L-DOPA—Hypertension—Betamethasone—systemic lupus erythematosus	0.000408	0.000942	CcSEcCtD
L-DOPA—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000408	0.000942	CcSEcCtD
L-DOPA—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000405	0.000936	CcSEcCtD
L-DOPA—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000405	0.000935	CcSEcCtD
L-DOPA—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000403	0.000931	CcSEcCtD
L-DOPA—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000401	0.000927	CcSEcCtD
L-DOPA—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000401	0.000925	CcSEcCtD
L-DOPA—Anxiety—Betamethasone—systemic lupus erythematosus	0.000401	0.000925	CcSEcCtD
L-DOPA—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000397	0.000917	CcSEcCtD
L-DOPA—Discomfort—Betamethasone—systemic lupus erythematosus	0.000397	0.000917	CcSEcCtD
L-DOPA—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000397	0.000917	CcSEcCtD
L-DOPA—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000397	0.000917	CcSEcCtD
L-DOPA—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000396	0.000915	CcSEcCtD
L-DOPA—Pain—Prednisolone—systemic lupus erythematosus	0.000395	0.000912	CcSEcCtD
L-DOPA—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000395	0.000912	CcSEcCtD
L-DOPA—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000393	0.000909	CcSEcCtD
L-DOPA—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000392	0.000906	CcSEcCtD
L-DOPA—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000391	0.000904	CcSEcCtD
L-DOPA—Nausea—Leflunomide—systemic lupus erythematosus	0.000391	0.000902	CcSEcCtD
L-DOPA—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.00039	0.000901	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000389	0.000899	CcSEcCtD
L-DOPA—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000389	0.000898	CcSEcCtD
L-DOPA—Vision blurred—Prednisone—systemic lupus erythematosus	0.000388	0.000895	CcSEcCtD
L-DOPA—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000387	0.000894	CcSEcCtD
L-DOPA—Pain—Hydrocortisone—systemic lupus erythematosus	0.000386	0.000891	CcSEcCtD
L-DOPA—Oedema—Dexamethasone—systemic lupus erythematosus	0.000385	0.00089	CcSEcCtD
L-DOPA—Oedema—Betamethasone—systemic lupus erythematosus	0.000385	0.00089	CcSEcCtD
L-DOPA—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000384	0.000887	CcSEcCtD
L-DOPA—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000383	0.000885	CcSEcCtD
L-DOPA—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000382	0.000881	CcSEcCtD
L-DOPA—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000381	0.000881	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000381	0.000879	CcSEcCtD
L-DOPA—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00038	0.000879	CcSEcCtD
L-DOPA—Anaemia—Prednisone—systemic lupus erythematosus	0.00038	0.000878	CcSEcCtD
L-DOPA—Shock—Betamethasone—systemic lupus erythematosus	0.000379	0.000876	CcSEcCtD
L-DOPA—Shock—Dexamethasone—systemic lupus erythematosus	0.000379	0.000876	CcSEcCtD
L-DOPA—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000379	0.000875	CcSEcCtD
L-DOPA—Agitation—Prednisone—systemic lupus erythematosus	0.000378	0.000873	CcSEcCtD
L-DOPA—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000377	0.000872	CcSEcCtD
L-DOPA—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000377	0.000872	CcSEcCtD
L-DOPA—Angioedema—Prednisone—systemic lupus erythematosus	0.000376	0.000868	CcSEcCtD
L-DOPA—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000374	0.000864	CcSEcCtD
L-DOPA—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000374	0.000864	CcSEcCtD
L-DOPA—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000373	0.000862	CcSEcCtD
L-DOPA—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000373	0.000861	CcSEcCtD
L-DOPA—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000373	0.000861	CcSEcCtD
L-DOPA—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000372	0.000859	CcSEcCtD
L-DOPA—Malaise—Prednisone—systemic lupus erythematosus	0.000371	0.000857	CcSEcCtD
L-DOPA—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000369	0.000852	CcSEcCtD
L-DOPA—Syncope—Prednisone—systemic lupus erythematosus	0.000369	0.000852	CcSEcCtD
L-DOPA—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000367	0.000849	CcSEcCtD
L-DOPA—Anorexia—Betamethasone—systemic lupus erythematosus	0.000367	0.000849	CcSEcCtD
L-DOPA—Urticaria—Prednisolone—systemic lupus erythematosus	0.000367	0.000847	CcSEcCtD
L-DOPA—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000366	0.000846	CcSEcCtD
L-DOPA—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000365	0.000844	CcSEcCtD
L-DOPA—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000365	0.000843	CcSEcCtD
L-DOPA—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000364	0.000841	CcSEcCtD
L-DOPA—Pain—Triamcinolone—systemic lupus erythematosus	0.000363	0.000839	CcSEcCtD
L-DOPA—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000361	0.000835	CcSEcCtD
L-DOPA—Hypotension—Betamethasone—systemic lupus erythematosus	0.00036	0.000832	CcSEcCtD
L-DOPA—Hypotension—Dexamethasone—systemic lupus erythematosus	0.00036	0.000832	CcSEcCtD
L-DOPA—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000359	0.000829	CcSEcCtD
L-DOPA—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000358	0.000828	CcSEcCtD
L-DOPA—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000357	0.000824	CcSEcCtD
L-DOPA—Convulsion—Prednisone—systemic lupus erythematosus	0.000356	0.000823	CcSEcCtD
L-DOPA—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000355	0.000821	CcSEcCtD
L-DOPA—Hypertension—Prednisone—systemic lupus erythematosus	0.000355	0.00082	CcSEcCtD
L-DOPA—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00035	0.000809	CcSEcCtD
L-DOPA—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00035	0.000808	CcSEcCtD
L-DOPA—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000349	0.000807	CcSEcCtD
L-DOPA—Anxiety—Prednisone—systemic lupus erythematosus	0.000349	0.000806	CcSEcCtD
L-DOPA—Alopecia—Methotrexate—systemic lupus erythematosus	0.000349	0.000806	CcSEcCtD
L-DOPA—Insomnia—Betamethasone—systemic lupus erythematosus	0.000349	0.000805	CcSEcCtD
L-DOPA—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000349	0.000805	CcSEcCtD
L-DOPA—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000347	0.000802	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000346	0.0008	CcSEcCtD
L-DOPA—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000346	0.000799	CcSEcCtD
L-DOPA—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000346	0.000799	CcSEcCtD
L-DOPA—Discomfort—Prednisone—systemic lupus erythematosus	0.000346	0.000799	CcSEcCtD
L-DOPA—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000346	0.000799	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.00034	0.000786	CcSEcCtD
L-DOPA—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000339	0.000784	CcSEcCtD
L-DOPA—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000339	0.000784	CcSEcCtD
L-DOPA—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000339	0.000782	CcSEcCtD
L-DOPA—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000337	0.000779	CcSEcCtD
L-DOPA—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000337	0.000778	CcSEcCtD
L-DOPA—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000337	0.000777	CcSEcCtD
L-DOPA—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000336	0.000775	CcSEcCtD
L-DOPA—Oedema—Prednisone—systemic lupus erythematosus	0.000336	0.000775	CcSEcCtD
L-DOPA—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000335	0.000774	CcSEcCtD
L-DOPA—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000335	0.000774	CcSEcCtD
L-DOPA—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000335	0.000774	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000333	0.000769	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000333	0.000769	CcSEcCtD
L-DOPA—Back pain—Methotrexate—systemic lupus erythematosus	0.000332	0.000768	CcSEcCtD
L-DOPA—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000332	0.000768	CcSEcCtD
L-DOPA—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000332	0.000767	CcSEcCtD
L-DOPA—Fatigue—Betamethasone—systemic lupus erythematosus	0.000332	0.000767	CcSEcCtD
L-DOPA—Shock—Prednisone—systemic lupus erythematosus	0.00033	0.000763	CcSEcCtD
L-DOPA—Pain—Betamethasone—systemic lupus erythematosus	0.00033	0.000761	CcSEcCtD
L-DOPA—Pain—Dexamethasone—systemic lupus erythematosus	0.00033	0.000761	CcSEcCtD
L-DOPA—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000327	0.000756	CcSEcCtD
L-DOPA—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000324	0.000749	CcSEcCtD
L-DOPA—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000324	0.000748	CcSEcCtD
L-DOPA—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000324	0.000748	CcSEcCtD
L-DOPA—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000323	0.000745	CcSEcCtD
L-DOPA—Rash—Cyclosporine—systemic lupus erythematosus	0.00032	0.000739	CcSEcCtD
L-DOPA—Anorexia—Prednisone—systemic lupus erythematosus	0.00032	0.000739	CcSEcCtD
L-DOPA—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.00032	0.000738	CcSEcCtD
L-DOPA—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000319	0.000737	CcSEcCtD
L-DOPA—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000319	0.000737	CcSEcCtD
L-DOPA—Headache—Cyclosporine—systemic lupus erythematosus	0.000318	0.000734	CcSEcCtD
L-DOPA—Anaemia—Methotrexate—systemic lupus erythematosus	0.000318	0.000734	CcSEcCtD
L-DOPA—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000318	0.000734	CcSEcCtD
L-DOPA—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000318	0.000734	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000315	0.000728	CcSEcCtD
L-DOPA—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000315	0.000728	CcSEcCtD
L-DOPA—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000315	0.000727	CcSEcCtD
L-DOPA—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000313	0.000723	CcSEcCtD
L-DOPA—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000312	0.000721	CcSEcCtD
L-DOPA—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000312	0.000721	CcSEcCtD
L-DOPA—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000312	0.00072	CcSEcCtD
L-DOPA—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00031	0.000716	CcSEcCtD
L-DOPA—Malaise—Methotrexate—systemic lupus erythematosus	0.00031	0.000716	CcSEcCtD
L-DOPA—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000309	0.000713	CcSEcCtD
L-DOPA—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000308	0.000711	CcSEcCtD
L-DOPA—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000306	0.000707	CcSEcCtD
L-DOPA—Urticaria—Betamethasone—systemic lupus erythematosus	0.000306	0.000707	CcSEcCtD
L-DOPA—Dizziness—Prednisolone—systemic lupus erythematosus	0.000305	0.000705	CcSEcCtD
L-DOPA—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000305	0.000704	CcSEcCtD
L-DOPA—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000305	0.000704	CcSEcCtD
L-DOPA—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000305	0.000704	CcSEcCtD
L-DOPA—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000304	0.000702	CcSEcCtD
L-DOPA—Insomnia—Prednisone—systemic lupus erythematosus	0.000304	0.000701	CcSEcCtD
L-DOPA—Nausea—Cyclosporine—systemic lupus erythematosus	0.000301	0.000696	CcSEcCtD
L-DOPA—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000301	0.000696	CcSEcCtD
L-DOPA—Pruritus—Triamcinolone—systemic lupus erythematosus	0.0003	0.000694	CcSEcCtD
L-DOPA—Cough—Methotrexate—systemic lupus erythematosus	0.0003	0.000693	CcSEcCtD
L-DOPA—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.0003	0.000693	CcSEcCtD
L-DOPA—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000298	0.000689	CcSEcCtD
L-DOPA—Convulsion—Methotrexate—systemic lupus erythematosus	0.000298	0.000688	CcSEcCtD
L-DOPA—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000295	0.000682	CcSEcCtD
L-DOPA—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000294	0.000679	CcSEcCtD
L-DOPA—Chest pain—Methotrexate—systemic lupus erythematosus	0.000293	0.000676	CcSEcCtD
L-DOPA—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000292	0.000674	CcSEcCtD
L-DOPA—Rash—Prednisolone—systemic lupus erythematosus	0.000291	0.000673	CcSEcCtD
L-DOPA—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000291	0.000672	CcSEcCtD
L-DOPA—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00029	0.00067	CcSEcCtD
L-DOPA—Fatigue—Prednisone—systemic lupus erythematosus	0.000289	0.000668	CcSEcCtD
L-DOPA—Headache—Prednisolone—systemic lupus erythematosus	0.000289	0.000668	CcSEcCtD
L-DOPA—Discomfort—Methotrexate—systemic lupus erythematosus	0.000289	0.000668	CcSEcCtD
L-DOPA—Constipation—Prednisone—systemic lupus erythematosus	0.000287	0.000663	CcSEcCtD
L-DOPA—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000287	0.000662	CcSEcCtD
L-DOPA—Rash—Hydrocortisone—systemic lupus erythematosus	0.000284	0.000657	CcSEcCtD
L-DOPA—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000284	0.000656	CcSEcCtD
L-DOPA—Confusional state—Methotrexate—systemic lupus erythematosus	0.000283	0.000653	CcSEcCtD
L-DOPA—Headache—Hydrocortisone—systemic lupus erythematosus	0.000283	0.000653	CcSEcCtD
L-DOPA—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000281	0.000649	CcSEcCtD
L-DOPA—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.00028	0.000647	CcSEcCtD
L-DOPA—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000277	0.000639	CcSEcCtD
L-DOPA—Asthenia—Betamethasone—systemic lupus erythematosus	0.000276	0.000639	CcSEcCtD
L-DOPA—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000276	0.000639	CcSEcCtD
L-DOPA—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000275	0.000634	CcSEcCtD
L-DOPA—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000274	0.000634	CcSEcCtD
L-DOPA—Nausea—Prednisolone—systemic lupus erythematosus	0.000274	0.000634	CcSEcCtD
L-DOPA—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000273	0.00063	CcSEcCtD
L-DOPA—Pruritus—Betamethasone—systemic lupus erythematosus	0.000273	0.00063	CcSEcCtD
L-DOPA—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000271	0.000626	CcSEcCtD
L-DOPA—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00027	0.000624	CcSEcCtD
L-DOPA—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000269	0.000622	CcSEcCtD
L-DOPA—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000268	0.000619	CcSEcCtD
L-DOPA—Rash—Triamcinolone—systemic lupus erythematosus	0.000268	0.000619	CcSEcCtD
L-DOPA—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000268	0.000618	CcSEcCtD
L-DOPA—Anorexia—Methotrexate—systemic lupus erythematosus	0.000267	0.000618	CcSEcCtD
L-DOPA—Rash—Methylprednisolone—systemic lupus erythematosus	0.000267	0.000617	CcSEcCtD
L-DOPA—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000267	0.000617	CcSEcCtD
L-DOPA—Urticaria—Prednisone—systemic lupus erythematosus	0.000267	0.000616	CcSEcCtD
L-DOPA—Headache—Triamcinolone—systemic lupus erythematosus	0.000266	0.000615	CcSEcCtD
L-DOPA—Headache—Methylprednisolone—systemic lupus erythematosus	0.000265	0.000613	CcSEcCtD
L-DOPA—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000265	0.000613	CcSEcCtD
L-DOPA—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000264	0.000609	CcSEcCtD
L-DOPA—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000264	0.000609	CcSEcCtD
L-DOPA—Hypotension—Methotrexate—systemic lupus erythematosus	0.000262	0.000605	CcSEcCtD
L-DOPA—Dizziness—Betamethasone—systemic lupus erythematosus	0.000255	0.000589	CcSEcCtD
L-DOPA—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000255	0.000589	CcSEcCtD
L-DOPA—Insomnia—Methotrexate—systemic lupus erythematosus	0.000254	0.000586	CcSEcCtD
L-DOPA—Nausea—Triamcinolone—systemic lupus erythematosus	0.000252	0.000583	CcSEcCtD
L-DOPA—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000252	0.000582	CcSEcCtD
L-DOPA—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000252	0.000581	CcSEcCtD
L-DOPA—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.00025	0.000578	CcSEcCtD
L-DOPA—Somnolence—Methotrexate—systemic lupus erythematosus	0.000249	0.000576	CcSEcCtD
L-DOPA—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000247	0.000571	CcSEcCtD
L-DOPA—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000247	0.00057	CcSEcCtD
L-DOPA—Vomiting—Betamethasone—systemic lupus erythematosus	0.000245	0.000566	CcSEcCtD
L-DOPA—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000245	0.000566	CcSEcCtD
L-DOPA—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000244	0.000563	CcSEcCtD
L-DOPA—Rash—Betamethasone—systemic lupus erythematosus	0.000243	0.000561	CcSEcCtD
L-DOPA—Rash—Dexamethasone—systemic lupus erythematosus	0.000243	0.000561	CcSEcCtD
L-DOPA—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000243	0.000561	CcSEcCtD
L-DOPA—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000243	0.000561	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000242	0.000559	CcSEcCtD
L-DOPA—Fatigue—Methotrexate—systemic lupus erythematosus	0.000242	0.000559	CcSEcCtD
L-DOPA—Headache—Betamethasone—systemic lupus erythematosus	0.000241	0.000558	CcSEcCtD
L-DOPA—Headache—Dexamethasone—systemic lupus erythematosus	0.000241	0.000558	CcSEcCtD
L-DOPA—Asthenia—Prednisone—systemic lupus erythematosus	0.000241	0.000556	CcSEcCtD
L-DOPA—Pain—Methotrexate—systemic lupus erythematosus	0.00024	0.000554	CcSEcCtD
L-DOPA—Pruritus—Prednisone—systemic lupus erythematosus	0.000237	0.000548	CcSEcCtD
L-DOPA—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000231	0.000534	CcSEcCtD
L-DOPA—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00023	0.00053	CcSEcCtD
L-DOPA—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000229	0.00053	CcSEcCtD
L-DOPA—Nausea—Betamethasone—systemic lupus erythematosus	0.000229	0.000529	CcSEcCtD
L-DOPA—Nausea—Dexamethasone—systemic lupus erythematosus	0.000229	0.000529	CcSEcCtD
L-DOPA—Urticaria—Methotrexate—systemic lupus erythematosus	0.000223	0.000515	CcSEcCtD
L-DOPA—Dizziness—Prednisone—systemic lupus erythematosus	0.000222	0.000513	CcSEcCtD
L-DOPA—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000222	0.000512	CcSEcCtD
L-DOPA—Vomiting—Prednisone—systemic lupus erythematosus	0.000213	0.000493	CcSEcCtD
L-DOPA—Rash—Prednisone—systemic lupus erythematosus	0.000212	0.000489	CcSEcCtD
L-DOPA—Dermatitis—Prednisone—systemic lupus erythematosus	0.000211	0.000488	CcSEcCtD
L-DOPA—Headache—Prednisone—systemic lupus erythematosus	0.00021	0.000486	CcSEcCtD
L-DOPA—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000207	0.000477	CcSEcCtD
L-DOPA—Asthenia—Methotrexate—systemic lupus erythematosus	0.000201	0.000465	CcSEcCtD
L-DOPA—Nausea—Prednisone—systemic lupus erythematosus	0.000199	0.00046	CcSEcCtD
L-DOPA—Pruritus—Methotrexate—systemic lupus erythematosus	0.000198	0.000458	CcSEcCtD
L-DOPA—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000192	0.000443	CcSEcCtD
L-DOPA—Dizziness—Methotrexate—systemic lupus erythematosus	0.000185	0.000428	CcSEcCtD
L-DOPA—Vomiting—Methotrexate—systemic lupus erythematosus	0.000178	0.000412	CcSEcCtD
L-DOPA—Rash—Methotrexate—systemic lupus erythematosus	0.000177	0.000408	CcSEcCtD
L-DOPA—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000177	0.000408	CcSEcCtD
L-DOPA—Headache—Methotrexate—systemic lupus erythematosus	0.000176	0.000406	CcSEcCtD
L-DOPA—Nausea—Methotrexate—systemic lupus erythematosus	0.000167	0.000385	CcSEcCtD
L-DOPA—DRD2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	9.64e-05	0.000298	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	9.62e-05	0.000297	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NCF2—systemic lupus erythematosus	9.56e-05	0.000295	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL12—systemic lupus erythematosus	9.55e-05	0.000295	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—C3—systemic lupus erythematosus	9.54e-05	0.000295	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—LYN—systemic lupus erythematosus	9.5e-05	0.000293	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	9.46e-05	0.000292	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—JAK1—systemic lupus erythematosus	9.36e-05	0.000289	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	9.34e-05	0.000288	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SH2B3—systemic lupus erythematosus	9.32e-05	0.000288	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	8.9e-05	0.000275	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.87e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	8.83e-05	0.000273	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—CCL2—systemic lupus erythematosus	8.78e-05	0.000271	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	8.75e-05	0.00027	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.74e-05	0.00027	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	8.71e-05	0.000269	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.7e-05	0.000269	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.67e-05	0.000268	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—C3—systemic lupus erythematosus	8.66e-05	0.000268	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—CCL2—systemic lupus erythematosus	8.66e-05	0.000267	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TLR9—systemic lupus erythematosus	8.65e-05	0.000267	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.6e-05	0.000265	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.48e-05	0.000262	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—C3—systemic lupus erythematosus	8.47e-05	0.000261	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—EP300—systemic lupus erythematosus	8.41e-05	0.00026	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—P2RY12—systemic lupus erythematosus	8.38e-05	0.000259	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—F2—systemic lupus erythematosus	8.38e-05	0.000259	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—IL6—systemic lupus erythematosus	8.1e-05	0.00025	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	8.02e-05	0.000247	CbGpPWpGaD
L-DOPA—PSIP1—Disease—IL6—systemic lupus erythematosus	7.94e-05	0.000245	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.92e-05	0.000244	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.91e-05	0.000244	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TLR9—systemic lupus erythematosus	7.79e-05	0.000241	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CSK—systemic lupus erythematosus	7.71e-05	0.000238	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TLR9—systemic lupus erythematosus	7.69e-05	0.000237	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.64e-05	0.000236	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—F2—systemic lupus erythematosus	7.61e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—JAK1—systemic lupus erythematosus	7.6e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.55e-05	0.000233	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—JUNB—systemic lupus erythematosus	7.5e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.45e-05	0.00023	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—F2—systemic lupus erythematosus	7.44e-05	0.00023	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—IL6—systemic lupus erythematosus	7.3e-05	0.000225	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CCR5—systemic lupus erythematosus	7.21e-05	0.000222	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—IL6—systemic lupus erythematosus	7.2e-05	0.000222	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	7.15e-05	0.000221	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.13e-05	0.00022	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.13e-05	0.00022	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	7.1e-05	0.000219	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NCF2—systemic lupus erythematosus	7.06e-05	0.000218	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—C3—systemic lupus erythematosus	7.04e-05	0.000217	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	7.03e-05	0.000217	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LYN—systemic lupus erythematosus	7.01e-05	0.000216	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CSK—systemic lupus erythematosus	6.94e-05	0.000214	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PRL—systemic lupus erythematosus	6.91e-05	0.000213	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.91e-05	0.000213	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.88e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CSK—systemic lupus erythematosus	6.85e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.85e-05	0.000211	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.78e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.75e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.66e-05	0.000206	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.63e-05	0.000205	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCR5—systemic lupus erythematosus	6.54e-05	0.000202	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6.49e-05	0.0002	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.49e-05	0.0002	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2RA—systemic lupus erythematosus	6.45e-05	0.000199	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.4e-05	0.000198	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—C3—systemic lupus erythematosus	6.39e-05	0.000197	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.39e-05	0.000197	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NCF2—systemic lupus erythematosus	6.35e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—C3—systemic lupus erythematosus	6.34e-05	0.000196	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PPARG—systemic lupus erythematosus	6.32e-05	0.000195	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LYN—systemic lupus erythematosus	6.31e-05	0.000195	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.31e-05	0.000195	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NCF2—systemic lupus erythematosus	6.27e-05	0.000193	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—C3—systemic lupus erythematosus	6.25e-05	0.000193	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LYN—systemic lupus erythematosus	6.23e-05	0.000192	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.22e-05	0.000192	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.19e-05	0.000191	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—F2—systemic lupus erythematosus	6.18e-05	0.000191	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TYK2—systemic lupus erythematosus	6.16e-05	0.00019	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.13e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.11e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	6.05e-05	0.000187	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.89e-05	0.000182	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TLR9—systemic lupus erythematosus	5.88e-05	0.000182	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.81e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.81e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—C3—systemic lupus erythematosus	5.76e-05	0.000178	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.73e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—P2RY12—systemic lupus erythematosus	5.7e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—C3—systemic lupus erythematosus	5.68e-05	0.000175	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ALB—systemic lupus erythematosus	5.68e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.64e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.64e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—F2—systemic lupus erythematosus	5.61e-05	0.000173	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—F2—systemic lupus erythematosus	5.57e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—JUNB—systemic lupus erythematosus	5.54e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—JAK1—systemic lupus erythematosus	5.53e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—systemic lupus erythematosus	5.51e-05	0.00017	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—F2—systemic lupus erythematosus	5.49e-05	0.00017	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NOS3—systemic lupus erythematosus	5.43e-05	0.000168	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5.38e-05	0.000166	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—RASGRP1—systemic lupus erythematosus	5.26e-05	0.000162	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CSK—systemic lupus erythematosus	5.24e-05	0.000162	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCR5—systemic lupus erythematosus	5.24e-05	0.000162	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	5.17e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.16e-05	0.000159	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—systemic lupus erythematosus	5.12e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—C3—systemic lupus erythematosus	5.12e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRL—systemic lupus erythematosus	5.1e-05	0.000157	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.08e-05	0.000157	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—F2—systemic lupus erythematosus	5.05e-05	0.000156	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL12—systemic lupus erythematosus	5.01e-05	0.000155	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCL2—systemic lupus erythematosus	5e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—F2—systemic lupus erythematosus	4.99e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—JUNB—systemic lupus erythematosus	4.98e-05	0.000154	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—systemic lupus erythematosus	4.97e-05	0.000153	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—JUNB—systemic lupus erythematosus	4.92e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.9e-05	0.000151	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.83e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NCF2—systemic lupus erythematosus	4.8e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—C3—systemic lupus erythematosus	4.79e-05	0.000148	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LYN—systemic lupus erythematosus	4.76e-05	0.000147	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.74e-05	0.000146	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.69e-05	0.000145	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.67e-05	0.000144	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.67e-05	0.000144	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRL—systemic lupus erythematosus	4.59e-05	0.000142	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.54e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRL—systemic lupus erythematosus	4.53e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.5e-05	0.000139	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—F2—systemic lupus erythematosus	4.49e-05	0.000139	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.45e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.44e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.38e-05	0.000135	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—C3—systemic lupus erythematosus	4.35e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CD80—systemic lupus erythematosus	4.31e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—F2—systemic lupus erythematosus	4.2e-05	0.00013	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—systemic lupus erythematosus	4.16e-05	0.000129	CbGpPWpGaD
L-DOPA—DDC—Metabolism—EP300—systemic lupus erythematosus	4.13e-05	0.000128	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	4.1e-05	0.000127	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.09e-05	0.000126	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—JAK1—systemic lupus erythematosus	4.08e-05	0.000126	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TYK2—systemic lupus erythematosus	4.04e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCL2—systemic lupus erythematosus	4.01e-05	0.000124	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR5—systemic lupus erythematosus	3.87e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.83e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—F2—systemic lupus erythematosus	3.82e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.81e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—systemic lupus erythematosus	3.78e-05	0.000117	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—C3—systemic lupus erythematosus	3.78e-05	0.000117	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—JUNB—systemic lupus erythematosus	3.76e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.75e-05	0.000116	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.7e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—JAK1—systemic lupus erythematosus	3.67e-05	0.000113	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TYK2—systemic lupus erythematosus	3.64e-05	0.000112	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—JAK1—systemic lupus erythematosus	3.62e-05	0.000112	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.58e-05	0.00011	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOS3—systemic lupus erythematosus	3.57e-05	0.00011	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR5—systemic lupus erythematosus	3.48e-05	0.000107	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRL—systemic lupus erythematosus	3.47e-05	0.000107	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR5—systemic lupus erythematosus	3.43e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.43e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—systemic lupus erythematosus	3.4e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.4e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—C3—systemic lupus erythematosus	3.4e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.38e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—systemic lupus erythematosus	3.36e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—C3—systemic lupus erythematosus	3.36e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—F2—systemic lupus erythematosus	3.32e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CD80—systemic lupus erythematosus	3.18e-05	9.82e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.09e-05	9.55e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.09e-05	9.54e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—systemic lupus erythematosus	3.03e-05	9.34e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—systemic lupus erythematosus	3.01e-05	9.3e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—F2—systemic lupus erythematosus	2.99e-05	9.22e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL2—systemic lupus erythematosus	2.96e-05	9.13e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—F2—systemic lupus erythematosus	2.95e-05	9.1e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MMP9—systemic lupus erythematosus	2.86e-05	8.84e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD80—systemic lupus erythematosus	2.86e-05	8.84e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.85e-05	8.81e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.83e-05	8.74e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD80—systemic lupus erythematosus	2.82e-05	8.72e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—JAK1—systemic lupus erythematosus	2.77e-05	8.56e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EP300—systemic lupus erythematosus	2.72e-05	8.38e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TYK2—systemic lupus erythematosus	2.68e-05	8.29e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL2—systemic lupus erythematosus	2.66e-05	8.22e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOS3—systemic lupus erythematosus	2.63e-05	8.13e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR5—systemic lupus erythematosus	2.63e-05	8.11e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL2—systemic lupus erythematosus	2.63e-05	8.11e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.59e-05	7.99e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.57e-05	7.94e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—systemic lupus erythematosus	2.57e-05	7.93e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—C3—systemic lupus erythematosus	2.57e-05	7.93e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TYK2—systemic lupus erythematosus	2.42e-05	7.46e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TYK2—systemic lupus erythematosus	2.38e-05	7.36e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOS3—systemic lupus erythematosus	2.37e-05	7.32e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.36e-05	7.29e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOS3—systemic lupus erythematosus	2.34e-05	7.23e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.3e-05	7.1e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.28e-05	7.05e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	2.25e-05	6.96e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—systemic lupus erythematosus	2.23e-05	6.9e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—systemic lupus erythematosus	2.22e-05	6.86e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	2.16e-05	6.67e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MMP9—systemic lupus erythematosus	2.11e-05	6.53e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.11e-05	6.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.05e-05	6.34e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.03e-05	6.26e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	2.01e-05	6.21e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	2.01e-05	6.2e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	2e-05	6.19e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	2e-05	6.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	1.98e-05	6.13e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	1.97e-05	6.09e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.9e-05	5.88e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.9e-05	5.86e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.9e-05	5.85e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	1.88e-05	5.8e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.87e-05	5.78e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.82e-05	5.63e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	1.8e-05	5.57e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.79e-05	5.53e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	1.78e-05	5.5e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—systemic lupus erythematosus	1.78e-05	5.49e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.74e-05	5.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.71e-05	5.28e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.69e-05	5.21e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.57e-05	4.84e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.55e-05	4.79e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.55e-05	4.78e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	1.52e-05	4.69e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.51e-05	4.66e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.45e-05	4.48e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.44e-05	4.44e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.43e-05	4.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	1.36e-05	4.21e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	1.31e-05	4.05e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.31e-05	4.03e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.29e-05	3.98e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.25e-05	3.86e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.18e-05	3.66e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	1.18e-05	3.65e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	1.17e-05	3.6e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.14e-05	3.53e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	9.5e-06	2.93e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	8.92e-06	2.75e-05	CbGpPWpGaD
